Alzheimer's in the Long COVID Era: What You Can Do Now

Millions of people are struggling with persistent brain fog, fatigue, and cognitive issues following COVID, not realizing these symptoms share striking similarities with neurodegenerative diseases like Alzheimer's. Both conditions represent what researchers call "network insufficiencies" in the brain, where chronic inflammation, toxins, and nutrient deficiencies create an imbalance that conventional medicine often fails to address effectively.

In this conversation, renowned Alzheimer's researcher Dr. Dale Bredesen, author of "The End of Alzheimer's," joins Dr. Eric Gordon to explore the connections between long COVID and brain health. They'll discuss practical strategies for resolving chronic inflammation, optimizing nutrients, and addressing the root causes that can help restore cognitive function and prevent future decline.

Episode Highlights:

• Anyone who has had COVID is at increased risk of developing Alzheimer's disease.
• Three types of toxins damage the brain: air pollution, organic solvents like glyphosate, and biotoxins from mold.
• Actionable steps you can take to protect your cognitive function
• Extra virgin olive oil outperformed expensive anti-amyloid drugs in Alzheimer's studies
• Hidden infections from the gums, gut, and sinuses can migrate to the brain and trigger harmful amyloid production
• COVID creates microthrombi (small blood clots) throughout the body that nattokinase or pycnogenol can help dissolve
• Poor ventilation and high CO2 levels in tight houses impair brain function, especially with gas stoves and many plants

Listen in to learn more : 

00:01) - COVID and Alzheimer's Connection Explained

(08:51) - Addressing Cognitive Decline Risks and Causes

(17:23) - Optimizing Treatment for Chronic Illness

(25:59) - Optimizing Cognitive Function and Treatment

(38:05) - Treating Chronic Illness and Toxin Exposure

(43:42) - Preventing Neurodegenerative Disease and COVID

(53:19) - Empowering Self-Care for Cognitive Health

About Dale Bredesen, MD

Dr. Bredesen graduated from Caltech and received his MD from Duke. He served as Resident and Chief Resident in Neurology at UCSF and was then a postdoctoral fellow with Nobel laureate Prof. Stanley Prusiner. He was the Founding President of the Buck Institute for Research on Aging.

The Bredesen Laboratory studied basic mechanisms underlying the neurodegenerative process and the translation into effective therapeutics for Alzheimer’s disease, leading to the publication of over 230 research papers. He established the Alzheimer’s Drug Development Network with Dr. Varghese John, leading to the identification of new classes of therapeutics for Alzheimer’s disease.  His work led to the discovery of subtypes of Alzheimer’s disease, followed by the first description of reversal of symptoms in patients with MCI and Alzheimer’s disease, with a precision medicine protocol, and a recent successful proof-of-co

💬 Text us your feedback and future show ideas! (Please note we can't respond to texts - email questions to [e-mail])

Gordon Medical Forum is now online! Register at https://gordonmedicalforum.com/ 

Interested in Becoming A Patient?

Find out if working with Gordon Medical is right for you. Set up a complimentary discovery call with our new patient coordinator at www.gordonmedical.com.

** This information is not to be taken as medical advice. Always consult your practitioner before making any changes to your treatment.